A hybrid enzyme-nanoparticle system is described for achieving clean reduction of CO 2 to CO using visible light as the energy source. An aqueous dispersion of TiO 2 nanoparticles modified by attachment of carbon monoxide dehydrogenase (CODH) and a Ru photosensitizer produces CO at a rate of 250 μmol CO (g TiO 2 ) -1 h -1 when illuminated with visible light at pH 6 and 20 °C.There is wide interest in converting the greenhouse gas CO 2 into organic molecules by chemical routes 1,2 and a highly desirable goal is to use solar energy to reduce CO 2 to CO, efficiently and cleanly. Carbon monoxide is the feedstock for various synthetic processes, such as the dmetal catalyzed Fischer-Tropsch (production of hydrocarbons), Monsanto and Cativa (both acetic acid) processes. Carbon monoxide also has significant fuel value (Δ c H° = −283.0 kJ mol -1 ), and can readily be converted into methanol (e.g., by the CuO/ZnO/Al 2 O 3 -catalyzed (Fig. S1), CO 2 photo-reduction using natural sunlight (Fig. S2), effect of centrifuging particles and exchanging buffer solution (Fig. S3), effect of pH (Fig. S4), UV-visible study of CODH I adsorption onto TiO 2 nanoparticles (Fig. S5), effect of initial CO concentration (Fig. S6), approximate calculation for CODH I loading on TiO 2 nanoparticles, full list of authors for ref. 12 . This material is available free of charge via the Internet at
A model system for photoreduction of CO 2 to CO using visible light has been extensively studied, using a catalyst for which the CO 2 /CO reaction is electrochemically reversible. The hybrid system comprises metal oxide nanoparticles functionalised with the enzyme carbon monoxide dehydrogenase (CODH), and sensitised to visible light using a ruthenium bipyridyl photosensitiser. An anatase/rutile TiO 2 mixture (Evonik Degussa P25) was selected as the most suitable semiconductor, and CO production rates and stability were examined as a function of each component (photosensitiser, enzyme and TiO 2 ). Tolerance to O 2 and effects of different electron donors were also investigated, together with strategies to control enzyme binding at the surface of TiO 2 in order to enhance overall activity.
Objectives: to evaluate orthogeriatric and nurse-led fracture liaison service (FLS) models of post-hip fracture care in terms of impact on mortality (30 days and 1 year) and second hip fracture (2 years).Setting: Hospital Episode Statistics database linked to Office for National Statistics mortality records for 11 acute hospitals in a region of England.Population: patients aged over 60 years admitted for a primary hip fracture from 2003 to 2013.Methods: each hospital was analysed separately and acted as its own control in a before–after time-series design in which the appointment of an orthogeriatrician or set-up/expansion of an FLS was evaluated. Multivariable Cox regression (mortality) and competing risk survival models (second hip fracture) were used. Fixed effects meta-analysis was used to pool estimates of impact for interventions of the same type.Results: of 33,152 primary hip fracture patients, 1,288 sustained a second hip fracture within 2 years (age and sex standardised proportion of 4.2%). 3,033 primary hip fracture patients died within 30 days and 9,662 died within 1 year (age and sex standardised proportion of 9.5% and 29.8%, respectively). The estimated impact of introducing an orthogeriatrician on 30-day and 1-year mortality was hazard ratio (HR) = 0.73 (95% CI: 0.65–0.82) and HR = 0.81 (CI: 0.75–0.87), respectively. Following an FLS, these associations were as follows: HR = 0.80 (95% CI: 0.71–0.91) and HR = 0.84 (0.77–0.93). There was no significant impact on time to second hip fracture.Conclusions: the introduction and/or expansion of orthogeriatric and FLS models of post-hip fracture care has a beneficial effect on subsequent mortality. No evidence for a reduction in second hip fracture rate was found.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.